About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | PRCT001 Aquablation theraPy Outcomes in pRostate Cancer patienTs

PRCT001 Aquablation theraPy Outcomes in pRostate Cancer patienTs

NCT06051942·6 sites·ClinicalTrials.gov

What this study is about

Take this into the appointment.

Saves the questions and what to expect into your notes, next to the visit they belong to.

Keep this study

Lead

PROCEPT BioRobotics

Age

0–80

Sex

MALE

Healthy volunteers

Not accepted

You may be eligible if

International Prostate Symptom Score (IPSS) ≥ 8
Gleason Grade Group 1-3
Prostate-specific Antigen (PSA) ≤20ng/mL
Cancer stage less than or equal to T2c

You may not be if

Patients with previous surgical treatment of benign prostatic hyperplasia
MRI evidence of extracapsular extension of cancer
Any severe illness that would prevent complete study participation or confound study results

The record

StatusActive not recruiting

PhaseNo phase

Taking part125

StartedNov 2022

UpdatedJan 28, 2026

Conditions

Benign Prostatic Hyperplasia Localized Prostate Cancer

Where6

San Diego Clinical Trials
La Mesa, California, United States
Endeavour Health (NorthShore University HealthSystem)
Glenview, Illinois, United States
Potomac Urology Center
Alexandria, Virginia, United States